Tuesday, November 17, 2026

HomeHealth NewsNoninvasive prenatal testing identifies twice as many Down syndrome cases as second-trimester...

Noninvasive prenatal testing identifies twice as many Down syndrome cases as second-trimester serum screening

- Advertisement -

Credit: BGI Genomics

A novel study has analyzed the cost-effectiveness of different Down syndrome (DS) screening strategies. The result confirms that noninvasive prenatal testing (NIPT) outperforms second-trimester serum screening (STSS) in accuracy and cost-effectiveness, as NIPT identifies twice as many DS cases as STSS.

…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed